SCHEMBL14887576

SCHEMBL14887576

Cc1nocc1C(=O)Nc1ccc(-c2cc3c(cc2Cl)OC(F)(F)O3)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 3/20 0.44
▸ STIM1 Q13586 3/20 0.42
▸ ORAI1 Q96D31 3/20 0.42
▸ ORAI2 Q96SN7 1/20 0.42
▸ ACR P10323 1/20 0.39
▸ POLQ O75417 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CSNK1D P48730 1/20 0.37
▸ CSNK1E P49674 1/20 0.37
▸ IL2 P60568 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ LCK P06239 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ GCGR P47871 1/20 0.36
▸ F2 P00734 1/20 0.36
▸ F10 P00742 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887583 0.90 SCN9A (0.43) SCN10ASTIM1ORAI1POLQCSNK1D
SCHEMBL14881535 0.88 STIM1 (0.49) SCN10ASTIM1ORAI1ORAI2POLQ
SCHEMBL14887584 0.84 STIM1 (0.42) STIM1ORAI1ORAI2ACRPOLQ
SCHEMBL16017253 0.83 STIM1 (0.43) STIM1ORAI1ORAI2ACRPOLQ
SCHEMBL16017272 0.81 STIM1 (0.43) STIM1ORAI1ORAI2ACRPOLQ
SCHEMBL2595935 0.81 SMO (0.55) ACRMAPT
SCHEMBL16017234 0.80 HSD17B10 (0.50) STIM1ORAI1ORAI2MAPTIL2
SCHEMBL16020566 0.80 STIM1 (0.62) SCN10ASTIM1ORAI1ORAI2POLQ
SCHEMBL16019776 0.80 ALDH1A1 (0.56) STIM1ORAI1ORAI2MAPT
SCHEMBL16017203 0.80 RAB9A (0.51) STIM1ORAI1ORAI2MAPTF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed
WO-2013059666-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 SCN10A 107/4885STIM1 17/4885ORAI1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback